Mesoblast reported 921K in Interest Income for its fiscal semester ending in June of 2024.


Interest Income Change Date
Cochlear AUD 7.4M 2.2M Dec/2024
CSL USD 18M 1000K Dec/2024
Pacific Edge NZD 1.19M 348K Sep/2024
PYC Therapeutics AUD 47.98K 10.51K Dec/2020
Telix Pharmaceuticals 1.37M 354K Jun/2024